- September 28, 2026
- Posted by: Tresmark
- Category:
No Comments
Selmore Pharmaceuticals Limited has applied for listing on the Main Board of the Pakistan Stock Exchange (PSX), according to a PSX notice issued on September 28.
The company plans to offer 48.61 million ordinary shares, each with a face value of Rs10, through the Book Building Method at a floor price of Rs42 per share.
At the floor price, the proposed offering would have a total value of approximately Rs2.04 billion. KTrade Securities Limited has been appointed as the lead manager for the issue.
PSX has placed the company’s draft prospectus on its website to invite public comments in accordance with the Public Offering Regulations, 2017.
Interested parties have been asked to submit their written comments on the draft prospectus by Monday, October 5, 2026, via the designated PSX email address.
